<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="editorial"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">11650330</article-id><article-id pub-id-type="doi">10.3346/jkms.2024.39.e334</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>In This Issue on 16-December-2024</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2611-3399</contrib-id><name><surname>Yoo</surname><given-names>Jin-Hong</given-names></name><role>Editor-in-Chief, Journal of Korean Medical Science</role><xref rid="A1-jkms-39-e334" ref-type="aff"/></contrib></contrib-group><aff id="A1-jkms-39-e334">Division of Infectious Diseases, Department of Internal Medicine, Bucheon St. Mary&#x2019;s Hospital, College of Medicine, The Catholic University of Korea, Seoul, <country>Korea</country>.</aff><author-notes><corresp>Address for Correspondence: Jin-Hong Yoo, MD, PhD. Division of Infectious Diseases, Department of Internal Medicine, Bucheon St. Mary&#x2019;s Hospital, College of Medicine, The Catholic University of Korea, 327 Sosa-ro, Wonmi-gu, Bucheon 14647, Republic of Korea. <email>editor.jkms@kams.or.kr</email></corresp></author-notes><pub-date pub-type="collection"><day>16</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>02</day><month>12</month><year>2024</year></pub-date><volume>39</volume><issue>48</issue><elocation-id>e334</elocation-id><permissions><copyright-statement>&#xA9; 2024 The Korean Academy of Medical Sciences.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Korean Academy of Medical Sciences</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions></article-meta></front><body><p>In this issue, 3 original articles have been published.</p><sec sec-type="other1" id="sec1-jkms-39-e334"><title>
<ext-link xlink:href="https://jkms.org/DOIx.php?id=10.3346/jkms.2024.39.e307" ext-link-type="uri">1. Challenge of Precautionary Allergen Labeling for Ensuring the Safety of Children With Food Allergies.</ext-link>
</title><p>Lee S, et al.</p><p>Precautionary allergen labeling (PAL) is mandatory in Korea. This study examined PAL use in baby food, finding it in 91.8% of products. ELISA tests showed only 16.67% of products were accurately labeled. Surveys from 207 guardians revealed dissatisfaction with current PAL, preferring 'allergen-free' statements. PAL was deemed excessive and ineffective for children's safety, necessitating revisions for a more evidence-based system. The study highlights the need for improved allergen labeling to better protect children with food allergies.</p></sec><sec sec-type="other2" id="sec2-jkms-39-e334"><title>
<ext-link xlink:href="https://jkms.org/DOIx.php?id=10.3346/jkms.2024.39.e301" ext-link-type="uri">2. Efficacy of Oral Sulfate Tablet and 2 L-Polyethylene Glycol With Ascorbic Acid for Bowel Preparation: A Prospective Randomized KASID Multicenter Trial.</ext-link>
</title><p>Kim HG, et al.</p><p>This study compared oral sulfate tablets (OSTs) with 2 L-polyethylene glycol plus ascorbic acid (2 L-PEG/ASC) for bowel preparation in 211 adults undergoing colonoscopy. OSTs showed significantly higher bowel cleansing rates in the right, transverse, and left colon. Both groups had similar successful cleansing rates, but OSTs were better in taste, ease of consumption, and willingness to repeat the procedure. Adverse events were comparable between groups. OSTs were not inferior to 2 L-PEG/ASC and showed better tolerability for colonoscopy preparation.</p></sec><sec sec-type="other3" id="sec3-jkms-39-e334"><title>
<ext-link xlink:href="https://jkms.org/DOIx.php?id=10.3346/jkms.2024.39.e300" ext-link-type="uri">3. Enhancing the Survival of Congenital Diaphragmatic Hernia: Quality Improvement Initiative With a Multidisciplinary Extracorporeal Membrane Oxygenation Team Approach.</ext-link>
</title><p>Lee BS, et al.</p><p>This study evaluated the impact of a multidisciplinary ECMO team approach (META) on the survival rates of neonates with congenital diaphragmatic hernia (CDH) and severe pulmonary hypertension. Reviewing medical records of 322 infants over 16 years, the study found that META significantly improved survival rates at NICU discharge from 66.3% to 82.9%. Key interventions included on-site ECMO management, venoarterial modality, and preplanned surgery. The survival rate for ECMO patients also improved from 21.1% to 56.7%, highlighting META's effectiveness in enhancing clinical outcomes.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>Disclosure:</bold> The author has no potential conflicts of interest to disclose.</p></fn></fn-group></back></article>
